Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions
Marco Trerotola1, Danielle L Jernigan, Qin Liu
1Prostate Cancer Discovery and Development Program, Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Cancer Research
|March 29, 2013
Summary
Trop-2 enhances prostate cancer cell migration and metastasis by interacting with beta(1) integrins. This interaction promotes cell movement on fibronectin, a key factor in cancer spread.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Background:
- Metastatic dissemination mechanisms remain unclear.
- Trop-2, a transmembrane molecule, is upregulated in carcinomas and affects beta(1) integrin signaling.
- Prostate cancer metastasis involves complex molecular interactions.
Purpose of the Study:
- To investigate Trop-2's role in prostate cancer cell metastasis and migration.
- To elucidate the molecular mechanisms by which Trop-2 influences cancer cell motility.
Main Methods:
- In vivo studies of prostate cancer cell dissemination.
- In vitro migration assays on fibronectin and vitronectin.
- Analysis of protein-protein interactions (Trop-2, alpha(5)beta(1) integrin, talin).
- Assessment of GTPase activity (Rac1) and kinase activation (PAK4).
Main Results:
- Trop-2 promotes prostate cancer cell metastasis in vivo and migration on fibronectin.
- Trop-2 associates with alpha(5)beta(1) integrin, leading to relocalization of key adhesion molecules.
- Trop-2 specifically enhances migration on fibronectin, not vitronectin, and modulates Rac1 and PAK4 activity.
- Trop-2 expression is abundant in human prostate cancer metastasis.
Conclusions:
- Trop-2 enhances beta(1) integrin-dependent prostate cancer cell migration and metastatic potential.
- Trop-2 acts as a key regulator of cancer cell motility and dissemination.
- Targeting Trop-2 may offer a therapeutic strategy for prostate cancer metastasis.
More Related Videos
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...